Log in to save to my catalogue

Cerebral Histamine H1 Receptor Binding Potential Measured with PET Under a Test Dose of Olopatadine,...

Cerebral Histamine H1 Receptor Binding Potential Measured with PET Under a Test Dose of Olopatadine,...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67305221

Cerebral Histamine H1 Receptor Binding Potential Measured with PET Under a Test Dose of Olopatadine, an Antihistamine, Is Reduced After Repeated Administration of Olopatadine

About this item

Full title

Cerebral Histamine H1 Receptor Binding Potential Measured with PET Under a Test Dose of Olopatadine, an Antihistamine, Is Reduced After Repeated Administration of Olopatadine

Publisher

United States: Soc Nuclear Med

Journal title

The Journal of nuclear medicine (1978), 2009-06, Vol.50 (6), p.887

Language

English

Formats

Publication information

Publisher

United States: Soc Nuclear Med

More information

Scope and Contents

Contents

Some antihistamine drugs that are used for rhinitis and pollinosis have a sedative effect as they enter the brain and block the H(1) receptor, potentially causing serious accidents. Receptor occupancy has been measured with PET under single-dose administration in humans to classify antihistamines as more sedating or as less sedating (or nonsedating...

Alternative Titles

Full title

Cerebral Histamine H1 Receptor Binding Potential Measured with PET Under a Test Dose of Olopatadine, an Antihistamine, Is Reduced After Repeated Administration of Olopatadine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67305221

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67305221

Other Identifiers

ISSN

0161-5505

E-ISSN

1535-5667

DOI

10.2967/jnumed.108.058537

How to access this item